These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27869314)

  • 1. Runx1 Orchestrates Sphingolipid Metabolism and Glucocorticoid Resistance in Lymphomagenesis.
    Kilbey A; Terry A; Wotton S; Borland G; Zhang Q; Mackay N; McDonald A; Bell M; Wakelam MJ; Cameron ER; Neil JC
    J Cell Biochem; 2017 Jun; 118(6):1432-1441. PubMed ID: 27869314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic Runx1-Myc axis in p53-deficient thymic lymphoma.
    Date Y; Taniuchi I; Ito K
    Gene; 2022 Apr; 819():146234. PubMed ID: 35114276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addiction to Runx1 is partially attenuated by loss of p53 in the Eµ-Myc lymphoma model.
    Borland G; Kilbey A; Hay J; Gilroy K; Terry A; Mackay N; Bell M; McDonald A; Mills K; Cameron E; Neil JC
    Oncotarget; 2016 Apr; 7(17):22973-87. PubMed ID: 27056890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Runx regulation of sphingolipid metabolism and survival signaling.
    Kilbey A; Terry A; Jenkins A; Borland G; Zhang Q; Wakelam MJ; Cameron ER; Neil JC
    Cancer Res; 2010 Jul; 70(14):5860-9. PubMed ID: 20587518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RUNX1 is required for oncogenic
    Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
    Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death.
    Nakamura N; Honjo M; Yamagishi R; Kurano M; Yatomi Y; Watanabe S; Aihara M
    Exp Eye Res; 2021 Jul; 208():108623. PubMed ID: 34022173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runx1 promotes B-cell survival and lymphoma development.
    Blyth K; Slater N; Hanlon L; Bell M; Mackay N; Stewart M; Neil JC; Cameron ER
    Blood Cells Mol Dis; 2009; 43(1):12-9. PubMed ID: 19269865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins.
    Anderson G; Mackay N; Gilroy K; Hay J; Borland G; McDonald A; Bell M; Hassanudin SA; Cameron E; Neil JC; Kilbey A
    J Cell Biochem; 2018 Mar; 119(3):2750-2762. PubMed ID: 29052866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53.
    Wotton SF; Blyth K; Kilbey A; Jenkins A; Terry A; Bernardin-Fried F; Friedman AD; Baxter EW; Neil JC; Cameron ER
    Oncogene; 2004 Jul; 23(32):5476-86. PubMed ID: 15133495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of core binding factorβ alters sphingolipid metabolism.
    Greer AH; Yong T; Fennell K; Moustafa YW; Fowler M; Galiano F; Ng SW; Berkowitz RS; Cardelli J; Meyers S; Davis JN
    J Cell Physiol; 2013 Dec; 228(12):2350-64. PubMed ID: 23813439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Runx genes: lineage-specific oncogenes and tumor suppressors.
    Cameron ER; Neil JC
    Oncogene; 2004 May; 23(24):4308-14. PubMed ID: 15156187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaboration of MYC and RUNX2 in lymphoma simulates T-cell receptor signaling and attenuates p53 pathway activity.
    Hay J; Gilroy K; Huser C; Kilbey A; Mcdonald A; MacCallum A; Holroyd A; Cameron E; Neil JC
    J Cell Biochem; 2019 Oct; 120(10):18332-18345. PubMed ID: 31257681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells.
    van Bragt MP; Hu X; Xie Y; Li Z
    Elife; 2014 Nov; 3():e03881. PubMed ID: 25415051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival.
    Wotton S; Terry A; Kilbey A; Jenkins A; Herzyk P; Cameron E; Neil JC
    Oncogene; 2008 Oct; 27(44):5856-66. PubMed ID: 18560354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond.
    Loh KC; Baldwin D; Saba JD
    Anticancer Agents Med Chem; 2011 Nov; 11(9):782-93. PubMed ID: 21707493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity.
    Aho TL; Sandholm J; Peltola KJ; Ito Y; Koskinen PJ
    BMC Cell Biol; 2006 May; 7():21. PubMed ID: 16684349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
    Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
    PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Runx transcription factors repress human and murine c-Myc expression in a DNA-binding and C-terminally dependent manner.
    Jacobs PT; Cao L; Samon JB; Kane CA; Hedblom EE; Bowcock A; Telfer JC
    PLoS One; 2013; 8(7):e69083. PubMed ID: 23874874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.
    Gao XY; Li L; Wang XH; Wen XZ; Ji K; Ye L; Cai J; Jiang WG; Ji JF
    Oncol Rep; 2015 Oct; 34(4):1977-87. PubMed ID: 26239167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis.
    Le Stunff H; Galve-Roperh I; Peterson C; Milstien S; Spiegel S
    J Cell Biol; 2002 Sep; 158(6):1039-49. PubMed ID: 12235122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.